Heterogeneity of Human γδ T Cells and Their Role in Cancer Immunity

Area of Science:

• Immunology
• Cancer Biology
• Cellular and Molecular Medicine

Background:

• Gamma delta (γδ) T cells are crucial lymphocytes in innate and adaptive immunity, responding to intracellular and infectious stresses.
• Their recognition of cancer-specific molecules and potential for cytotoxic differentiation highlight their immunotherapeutic promise.
• Conversely, γδ T cells can also drive tumor progression via cytokine secretion, necessitating a deeper understanding of their regulation.

Purpose of the Study:

• To elucidate the regulation of γδ T cell differentiation and homeostasis.
• To investigate the distinct functions of different γδ T cell subsets in cancer.
• To summarize recent advancements in human γδ T cell cancer immunology.

Main Methods:

• Review of current literature on γδ T cell development, heterogeneity, and plasticity.
• Analysis of mechanisms underlying γδ T cell ligand recognition and activation.
• Examination of the dual roles of γδ T cells in the tumor microenvironment.

Main Results:

• Human γδ T cells are broadly classified into Vδ2 and non-Vδ2 subsets, with Vγ9δ2 T cells recognizing specific pyrophosphorylated isoprenoids.
• Vδ1 T cells recognize diverse ligands, including growth factor receptors, and expand in disease contexts.
• Both Vδ1 and Vδ2 γδ T cells show immunotherapeutic potential, but distinct characteristics require further elucidation.

Conclusions:

• Detailed understanding of γδ T cell heterogeneity and function is essential for optimizing cancer immunotherapy.
• Elucidating the dual roles of γδ T cells in cancer immunology will enhance their therapeutic application.